(201 days)
Not Found
Not Found
No
The 510(k) summary describes a standard patient monitor with vital sign measurements and does not mention any AI/ML capabilities or related concepts like image processing, training/test sets, or performance metrics typically associated with AI/ML algorithms.
No
The device is described as a "Light Monitor" for "monitoring of patient's ECG, SpO2, body temperature, invasive and non-invasive blood pressures as well as respiration and CO2." Its function is solely for monitoring and not for treatment or therapy.
Yes
The device monitors various physiological parameters (ECG, SpO2, temperature, blood pressure, respiration, CO2) to assess a patient's health status, which is a core function of a diagnostic device.
No
The device description is not available, but the intended use clearly describes monitoring of various physiological parameters (ECG, SpO2, blood pressure, etc.) which inherently requires hardware sensors and components to acquire this data. The description of use in hospitals and ambulances, and the mention of a protective case for outdoor use, further suggest a physical device.
Based on the provided information, the Datex-Engstrom Light Monitor, F-LM1, F-LMP1 is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- The intended use of the Datex-Engstrom Light Monitor is for monitoring physiological parameters directly from the patient's body (ECG, SpO2, temperature, blood pressure, respiration, CO2). It does not involve the analysis of in vitro specimens.
Therefore, this device falls under the category of patient monitoring equipment, not IVD.
N/A
Intended Use / Indications for Use
The Datex-Engstrom Light Monitor, F-LM1, F-LMP1 is for stationary and mobile monitoring of patient's ECG, SpO2, body temperature, invasive and non-invasive blood pressures as well as respiration and CO2 in hospitals and ambulances. When used outdoors, the monitor must be in the protective case.
Product codes
74 DRT
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
The Light Monitor is intended for patients with weight of 5kg (11lb.) or more. Respiration monitoring is intended for patients ages 3 and up.
Intended User / Care Setting
The monitor is intended for use by qualified medical personnel only.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around it. Inside the circle is a stylized image of an eagle with three human profiles incorporated into its design.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
3 1998 NOV
Mr. Joel C. Kent Datex-Engstrom, Inc. 3 Highwood Drive Tewksbury, MA 01876
Re: K981378 Datex-Engstrom Light Monitor F-LM1, F-LMP1 Requlatory Class: II (two) Product Code: 74 DRT Dated: August 6, 1998 Received: August 7, 1998
Dear Mr. Kent:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, qood manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, r other Federal laws or regulations.
1
Page 2 - Mr. Joel C. Kent
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Thomas J. Callehan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Device Name:
Indications For Use:
The Datex-Engstrom Light Monitor, F-LM1, F-LMP1 is for stationary and mobile monitoring of patient's ECG, SpO2, body temperature, invasive and non-invasive blood pressures as well as respiration and CO2 in hospitals and ambulances. When used outdoors, the monitor must be in the protective case.
The monitor is intended for use by qualified medical personnel only. The Light Monitor is intended for patients with weight of 5kg (11lb.) or more. Respiration monitoring is intended for patients ages 3 and up.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) |
|---|
| -------------------------------------------------------- |
| Lmk Madow | 11-2-98 | |
|---|---|---|
| -- | ----------- | --------- |
| Prescription Use | |
|---|---|
| (Per 21 CFR 801.109) |
| (Division Sign-Off) | Over-The-Counter Use |
|---|---|
| Division of Cardiovascular, Respiratory, and Neurological Devices | (Optional Format 1-2-96) |
| 510(k) Number | |
|---|---|
| --------------- | -- |